Enhancing Viral Transduction in Natural Killer Cells Using a Cationic Polymer
JoVE Encyclopedia of Experiments
Immunology
0 views • 4:21 min • July 8th, 2025
Take natural killer, or NK, cells. Add lentivirus vectors comprising viral enzymes and engineered RNA molecules that encode a fluorescent protein.
Add cationic polymers and sediment the cells and viruses.
The polymers neutralize the negative charges on both the virus and the cell, facilitating membrane fusion.
The RNA is reverse-transcribed into DNA and integrated into the host genome, enabling fluorescent protein expression.
Add media supplemented with the cytokine interleukin-2, or IL-2.
IL-2 triggers intracellular signaling that promotes NK cell survival and proliferation while preserving transgene expression.
Transfer the mixture to a well coated with antibodies that bind to specific immunoreceptors on NK cells, triggering them to release antiviral cytokines.
Quantify the released cytokines to assess the polymer's impact on cytokine production.
Add fluorescent dyes to label the DNA of necrotic cells.
Using flow cytometry, identify live cells and quantify the fluorescent protein's signal to measure the efficiency of polymer-induced transduction.
Suspend mouse or human primary NK cells in the wells of a 24-well plate at 0.5 x 105 per milliliter of medium with GFP lentivirus supernatant at an MOY of 5, 10, and 20 and in the presence of polybrene, protamine sulfate, or dextran.
Centrifuge the plates at 1,000 times g for 60 minutes. Then, without decanting the supernatant, culture the cells in a 37 degrees Celsius incubator infused with 5.2% carbon dioxide overnight. After the cells have been washed with 10 milliliters of PBS, use 2 milliliters of RPMI 1640 medium with IL-2 to resuspend the cells.
The day before harvesting the cells, coat 96-well highly protein absorbent polystyrene plates with 2.5 micrograms per milliliter of anti-NKG2D monoclonal antibodies, and incubate the plates at room temperature or in the fridge overnight. The following day, use 100 microliters of PBS to wash each well three times.
Harvest the transduced NK cells by first gently tapping the plates. Then add 100 microliters of the cells to each well of the 96-well plates. 16 to 18 hours post-activation, use a multichannel pipette to collect the supernatants. Then, using the recombinant cytokines from an ELISA kit, generate a standard curve and quantify the cytokines such as interferon-gamma in the supernatant.
To test the NK cell viability, four days after transduction, wash the cells with 10 milliliters of cold PBS two times. Then, harvest the cells and use an annexin-V/7-amino-actinomycin D to stain them. Use flow cytometry to determine the percent of necrotic cells among the transformed NK cells, and analyze the data according to the text protocol.
Overview
This article discusses the transduction of natural killer (NK) cells using lentivirus vectors and cationic polymers. The process enhances NK cell survival and proliferation while enabling the expression of a fluorescent protein.
Key Study Components
Area of Science
- Cellular Biology
- Immunology
- Gene Therapy
Background
- Natural killer (NK) cells play a crucial role in the immune response.
- Lentivirus vectors are used for gene delivery into cells.
- Cationic polymers can facilitate the transduction process.
- Interleukin-2 (IL-2) supports NK cell survival and function.
Purpose of Study
- To enhance the efficiency of NK cell transduction.
- To assess the impact of cationic polymers on cytokine production.
- To evaluate NK cell viability post-transduction.
Methods Used
- Preparation of NK cells and lentivirus vectors.
- Use of cationic polymers to facilitate membrane fusion.
- Flow cytometry for quantifying transduced cells and cytokines.
- ELISA for measuring cytokine levels in supernatants.
Main Results
- Successful transduction of NK cells with fluorescent protein expression.
- Increased cytokine production observed with polymer treatment.
- Flow cytometry analysis revealed cell viability and necrosis rates.
- IL-2 supplementation enhanced NK cell proliferation.
Conclusions
- Cationic polymers significantly improve NK cell transduction efficiency.
- Enhanced cytokine production indicates a functional response.
- The methodology can be applied to further studies in immunotherapy.
Frequently Asked Questions
Executive Industry Relevance
Enhancing lentiviral transduction efficiency in primary natural killer (NK) cells addresses a key bottleneck in immunotherapy development, where low transfection rates limit functional validation of engineered receptors and transgenes. By using cationic polymers to overcome electrostatic barriers, this method improves predictive confidence in target de-risking and supports scalable workflows for NK cell-based therapeutic candidates. The approach enables quantitative assessment of transgene expression and cytokine functionality, informing early go/no-go decisions in immunotherapy pipeline advancement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional interrogation of transgene expression in primary NK cells to validate immunological targets and signaling pathways.
- Operational Value: Provides a reproducible system for assessing transgene integration and expression efficiency under controlled cytokine conditions.
- Predictive Value: Supports mechanistic de-risking by linking polymer-enhanced transduction to downstream cytokine secretion as a functional readout.
Screening & Assay Development
- Assay Readiness: Generates quantifiable fluorescent protein expression as a surrogate marker for transduction efficiency across polymer and viral dose conditions.
- Reproducibility: Standardizes centrifugation, incubation, and IL-2 supplementation steps to minimize variability in primary cell transduction assays.
- Scalability: Uses 24-well and 96-well plate formats compatible with medium-throughput screening of transduction enhancers.
Translational & Preclinical Research
- Translational Continuity: Maintains NK cell viability and transgene expression post-transduction, enabling functional assays such as cytokine release profiling.
- Preclinical Modeling: Supports evaluation of engineered NK cells in immunomodulatory contexts relevant to tumor immunotherapy.
- Risk-Adjusted Advancement: Links transduction efficiency to functional output (e.g., IFN-γ secretion), informing prioritization of lead constructs.
Pipeline & Workflow Integration
This method fits within the discovery-to-preclinical continuum by enabling stable gene delivery into primary NK cells, a critical step for validating chimeric antigen receptors (CARs) or immunomodulatory transgenes before in vivo testing.
- Discovery Biology: Facilitates hypothesis testing of transgene function in primary immune cells through detectable fluorescent and cytokine readouts.
- Screening: Enables comparison of cationic polymers (e.g., dextran, polybrene) for transduction optimization in primary NK cells.
- Analytics: Employs flow cytometry and ELISA to quantify transgene expression and cytokine secretion, providing multidimensional functional data.
- Translational Research: Preserves NK cell viability and activation capacity post-transduction, supporting continuity to preclinical validation.
- Enterprise Reuse: Establishes a reusable platform for evaluating genetic modifications in primary NK cells across immunotherapy programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in transgene expression and reduces false negatives in target validation assays.
- Operational Value: Standardizes transduction of hard-to-transfect primary NK cells using defined polymer-virus-cell ratios.
- Strategic Value: Improves capital efficiency by increasing success rates of NK cell engineering experiments.
- Portfolio Impact: Enables risk-adjusted prioritization of transgene candidates based on validated expression and functional activity.
Implementation Considerations
- Requires expertise in primary immune cell culture and lentiviral handling under biosafety level 2 conditions.
- Depends on access to flow cytometry and ELISA platforms for quantification of transduction and cytokine outputs.
- Necessitates standardization of IL-2 supplementation and incubation times to maintain NK cell phenotype and function.
- Involves optimization of polymer type and concentration (e.g., dextran, protamine sulfate) across murine and human NK cell sources.
- Limited by donor variability in primary NK cell transduction efficiency, requiring internal controls for inter-experiment comparison.
Biopharma FAQs
Laser-assisted Lentiviral Gene Delivery to Mouse Fertilized Eggs
Related Videos
0 Views
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Related Videos
0 Views
Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Related Videos
0 Views
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Related Videos
0 Views
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
Related Videos
0 Views
Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
Related Videos
0 Views
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Related Videos
0 Views
Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
Related Videos
0 Views
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Related Videos
0 Views
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
Related Videos
0 Views
Last updated: 29 August 2026